Skip to search.
 FTSE 100 Up 0.70%

More On BTGGF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

BTG plc (BTGGF)

-Other OTC
9.78 0.00(0.00%) 24 May 14:39
Prev Close:9.78
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:0.592127
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:8.00 - 11.14
Volume:0
Avg Vol (3m):2,098
Market Cap:3.74b
P/E (ttm):43.47
EPS (ttm):0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.32
P/S (ttm):5.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-17) :22.86
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):1.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc, a specialist healthcare company, acquires, develops, and commercializes pharmaceutical products worldwide. It operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback